On February 6, 2024, Point72 Asset Management, led by Steven Cohen (Trades, Portfolio), made a significant move in the biotechnology sector by purchasing 1,692,778 shares of Alto Neuroscience Inc (NYSE:ANRO). Steven A. Cohen, the Chairman and CEO of Point72 Asset Management, is a prominent figure in the investment world.